Low-dose clarithromycin therapy modulates Th17 response in non-cystic fibrosis bronchiectasis patients.
about
Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation.Effects of Low-Dose and Long-Term Treatment with Erythromycin on Interleukin-17 and Interleukin-23 in Peripheral Blood and Induced Sputum in Patients with Stable Chronic Obstructive Pulmonary Disease.Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis.Update in Bronchiectasis 2014.The Immunomodulatory Effects of Macrolides-A Systematic Review of the Underlying Mechanisms.
P2860
Low-dose clarithromycin therapy modulates Th17 response in non-cystic fibrosis bronchiectasis patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Low-dose clarithromycin therap ...... rosis bronchiectasis patients.
@en
Low-dose clarithromycin therap ...... rosis bronchiectasis patients.
@nl
type
label
Low-dose clarithromycin therap ...... rosis bronchiectasis patients.
@en
Low-dose clarithromycin therap ...... rosis bronchiectasis patients.
@nl
prefLabel
Low-dose clarithromycin therap ...... rosis bronchiectasis patients.
@en
Low-dose clarithromycin therap ...... rosis bronchiectasis patients.
@nl
P2093
P2860
P50
P1433
P1476
Low-dose clarithromycin therap ...... rosis bronchiectasis patients.
@en
P2093
Antonios Antoniadis
Eleftheria Lamprianidou
Emmanouil Paraskakis
Evangelia Fouka
Ioannis Kotsianidis
Konstantinos Arvanitidis
Paraskevi Miltiades
P2860
P2888
P304
P356
10.1007/S00408-014-9619-0
P577
2014-07-14T00:00:00Z